Evidence map›Paper›PMID 39918572›Full record

ArticleHuman genetics2025

Unilateral, bilateral symmetric or asymmetric isolated hearing loss in patients with heterozygous KITLG variants.

Margaux Serey-Gaut, Ralyath Balogoun, Laurence Jonard, Geneviève Lina-Granade, Renaud Touraine, Marjolaine Willems, Nicola Hepp, Nanna Dahl Rendtorff, Mette Bertelsen, Natalie Loundon and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Margaux Serey-GautCentre de Recherche en Audiologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.ORCID http://orcid.org/0000-0002-1165-0872
Ralyath BalogounService de Médecine Génomique des Maladies Rares, AP-HP. Centre, Hôpital Necker-Enfants Malades, Paris, F-75015, France.
Laurence JonardService de Médecine Génomique des Maladies Rares, AP-HP. Centre, Hôpital Necker-Enfants Malades, Paris, F-75015, France.
Geneviève Lina-GranadeORL audiophonologie, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
Renaud TouraineService de Génétique Clinique, Chromosomique et Moléculaire, CHU de Saint Etienne, Hôpital Nord, Saint Etienne, France.
Marjolaine WillemsGénétique Clinique, CHU Montpellier, Montpellier, France.
Nicola HeppDepartment of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, 2100, Denmark.
Nanna Dahl RendtorffDepartment of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, 2100, Denmark.
Mette BertelsenDepartment of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, 2100, Denmark.
Natalie LoundonCentre de Recherche en Audiologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
Vincent CouloignerService d'ORL Pédiatrique et de Chirurgie Cervico-Faciale, AP-HP, Hôpital Necker-Enfants Malades, Université de Paris Cité, Paris, France.
Isabelle LemiereService de Médecine Génomique des Maladies Rares, AP-HP. Centre, Hôpital Necker-Enfants Malades, Paris, F-75015, France.
Judite de OliveiraService de Médecine Génomique des Maladies Rares, AP-HP. Centre, Hôpital Necker-Enfants Malades, Paris, F-75015, France.
Serge RomanaService de Médecine Génomique des Maladies Rares, AP-HP. Centre, Hôpital Necker-Enfants Malades, Paris, F-75015, France.
Camille PorteretLaboratoire de Biologie Médicale Multi-Sites SeqOIA, Paris, France.
Pierre BlancLaboratoire de Biologie Médicale Multi-Sites SeqOIA, Paris, France.
Luke MansardLaboratoire de Génétique Moléculaire, LBMR Pathologies Neurosensorielles Rares, CHU Montpellier, Montpellier, France.
Sandrine MarlinCentre de Recherche en Audiologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
Anne-Françoise RouxLaboratoire de Génétique Moléculaire, LBMR Pathologies Neurosensorielles Rares, CHU Montpellier, Montpellier, France.
Véronique PingaultService de Médecine Génomique des Maladies Rares, AP-HP. Centre, Hôpital Necker-Enfants Malades, Paris, F-75015, France. Veronique.pingault@inserm.fr.ORCID http://orcid.org/0000-0001-7064-0765

Funding

Agence Nationale de la Recherche ANR-10-IAHU-01
6 · The paper itself

Abstract

KITLG pathogenic variants have been associated to three distinct clinical presentations with different combinations of hearing loss and/or pigmentation abnormalities. However, its involvement in isolated hearing loss has not been confirmed since its initial description in two families. Besides, KITLG is so far the only gene prevailingly involved in unilateral isolated hearing loss. We therefore conducted a retrospective study of patients with KITLG alterations in the French national Reference Network for Genetic Hearing Loss and one case was added through the Genematcher exchange platform. We describe a series of monoallelic KITLG deletions and variations in a cohort of 14 symptomatic patients from eight unrelated families. All patients presented with unilateral, bilateral symmetric or asymmetric sensorineural hearing loss. When not profound, hearing loss was predominant on low frequencies. Most KITLG alterations are likely to result in loss-of-function and aggregate in the extracellular region, disrupting the KIT-binding domain or its structure. Penetrance is not complete, and unspecific pigmentation alterations were observed in only three patients. The present study confirms KITLG involvement in isolated unilateral, bilateral symmetric or asymmetric hearing loss. This confirmation indicates that genetic testing can be relevant in early-onset, non-sudden, isolated unilateral hearing loss.

Indexed as

Hearing Loss, BilateralHearing Loss, SensorineuralHearing Loss, UnilateralAdolescentAdultChildChild, PreschoolFemaleHeterozygoteHumansMaleMiddle AgedMutationPedigreeRetrospective StudiesYoung Adult

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.